Additionally, it is worth mentioning that DM represents the end stage of a chronic and progressive heterogeneous syndrome characterized by a series of metabolic disorders (dysglycemia and dyslipidemia), promoted by environmental factors, genetic susceptibility, insulin resistance, and a decrease in hormone secretion by pancreatic β cells [12, 13]. Here, INS is linked to metabolic syndrome.